Skip to main content
. 2017 Nov 29;12(11):e0188712. doi: 10.1371/journal.pone.0188712

Fig 2. Gastrointestinal adverse events by study week.

Fig 2

Discontinuations because of gastrointestinal treatment-emergent adverse events during the randomized periods (ferric citrate [5.3%] vs. placebo [1.1%]).